Purchase Order HHSN272201500565P
Award Date 4/17/15
Potential Completion Date 4/24/15
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIAID DEA OA Acquisitions) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, for the provision of SEQUENCING KITS. The contract has a ceiling value of $4,317.81 and an ultimate completion date of July 30, 2015. There was no set-aside designation for this award. Illumina, a for-profit organization, has a history of providing a range of sequencing...
- This is a firm fixed price purchase order issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc. for sequencing kits. The contract has a ceiling value of $8,381.13 and a performance period ending on August 18, 2015. Illumina is a manufacturer of DNA sequencing and array-based solutions for genetic and genomic analysis. This award does not have a set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and bioinformatics...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of sequencing kits, with a ceiling value of $7,012.50 and a period of performance from May 15, 2014 to May 23, 2014. The contract has no set-aside designation. Illumina has a history of providing...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for a sample preparation kit. The contract has a ceiling value of $3,889.60 and a completion date of August 12, 2015. Illumina is a manufacturer of genetic sequencing instruments and reagents, and has previously received prime federal contracts and subcontracts from agencies like the NIH, CDC, USDA, and VA to...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for cycles of DNA sequencing services. The contract has a ceiling value of $5,548.11 and a completion date of September 3, 2013. Illumina, a manufacturer of sequencing and array-based genomic analysis instruments and reagents, has provided a range of sequencing systems and related products to support...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of TruSeq sequencing kits. The contract, valued at $12,697.30, has no set-aside designation and is for the ultimate completion of the order by September 5, 2014. Illumina, a manufacturer of sequencing and array-based genomic analysis instruments and reagents, has a history of providing...
- This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $15,807.96 award provides Illumina's proprietary sequencing systems, reagents, and services to support nucleic acid sequencing needs, with no set-aside designation. The order is part of a larger Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery, valued up...
- This is a $7,460.28 firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The order is for Illumina's NextSeq 500/550 High Output Kit V2 (150 cycles), with a completion date of July 15, 2017. There is no set-aside designation for this award. Illumina has previously received prime federal contract and...
- This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of consumables to support Illumina's genetic sequencing equipment. The contract has a total ceiling value of $108,694.36 and a completion date of November 16, 2021. Illumina is a manufacturer of sequencing and analysis solutions for life science research, applied markets, and molecular...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the prime contractor Illumina, Inc. for the purchase of MiSeq sequencing kits. The order, valued at $13,071, does not have a set-aside designation. Illumina is a for-profit manufacturer and provider of genetic sequencing and analysis instruments and reagents. The award supports NIAID's genomic research and diagnostics...